Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Berghmans T, Lafitte JJ, Paesmans M, Stach B, Berchier MC, Wackenier P, Lecomte J, Collon T, Mommen P, Sculier JP; European Lung Cancer Working Party (ELCWP). Berghmans T, et al. Among authors: paesmans m. Lung Cancer. 2005 Oct;50(1):75-82. doi: 10.1016/j.lungcan.2005.05.007. Lung Cancer. 2005. PMID: 16005104 Clinical Trial.
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
Sculier JP, Paesmans M, Bureau G, Dabouis G, Libert P, Vandermoten G, Van Cutsem O, Berchier MC, Ries F, Michel J, et al. Sculier JP, et al. Among authors: paesmans m. J Clin Oncol. 1993 Oct;11(10):1858-65. doi: 10.1200/JCO.1993.11.10.1858. J Clin Oncol. 1993. PMID: 8410110 Clinical Trial.
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).
Borges M, Sculier JP, Paesmans M, Richez M, Bureau G, Dabouis G, Lecomte J, Michel J, Van Cutsem O, Schmerber J, Giner V, Berchier MC, Sergysels R, Mommen P, Klastersky J. Borges M, et al. Among authors: paesmans m. Lung Cancer. 1996 Dec;16(1):21-33. doi: 10.1016/s0169-5002(96)00609-5. Lung Cancer. 1996. PMID: 9017582
Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Efremidis A, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: paesmans m. J Clin Oncol. 1998 Apr;16(4):1388-96. doi: 10.1200/JCO.1998.16.4.1388. J Clin Oncol. 1998. PMID: 9552042 Clinical Trial.
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy. The European Lung Cancer Working Party.
Sculier JP, Paesmans M, Ninane V, Giner V, Bureau G, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Berchier MC, Zacharias C, Mommen P, van Houtte P, Klastersky J. Sculier JP, et al. Among authors: paesmans m. Lung Cancer. 1998 Dec;22(3):201-13. doi: 10.1016/s0169-5002(98)00089-0. Lung Cancer. 1998. PMID: 10048473
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Lafitte JJ, Baumöhl J, Thiriaux J, van Cutsem O, Recloux P, Bureau G, Berchier MC, Zacharias C, Mommen P, Bosschaerts T, Berghmans T, van Houtte P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: paesmans m. Ann Oncol. 1999 Mar;10(3):295-303. doi: 10.1023/a:1008319506107. Ann Oncol. 1999. PMID: 10355573 Free article. Clinical Trial.
A comparison of methods of calculation for estimating carboplatin AUC with a retrospective pharmacokinetic-pharmacodynamic analysis in patients with advanced non-small cell lung cancer. European Lung Cancer Working Party.
Sculier JP, Paesmans M, Thiriaux J, Lecomte J, Bureau G, Giner V, Koumakis G, Lafitte JJ, Berchier MC, Alexopoulos CG, Zacharias C, Mommen P, Ninane V, Klastersky J. Sculier JP, et al. Among authors: paesmans m. Eur J Cancer. 1999 Sep;35(9):1314-9. doi: 10.1016/s0959-8049(99)00029-5. Eur J Cancer. 1999. PMID: 10658520 Clinical Trial.
Prognostic factors for patients with small cell lung carcinoma: analysis of a series of 763 patients included in 4 consecutive prospective trials with a minimum follow-up of 5 years.
Paesmans M, Sculier JP, Lecomte J, Thiriaux J, Libert P, Sergysels R, Bureau G, Dabouis G, Van Cutsem O, Mommen P, Ninane V, Klastersky J. Paesmans M, et al. Cancer. 2000 Aug 1;89(3):523-33. doi: 10.1002/1097-0142(20000801)89:3<523::aid-cncr7>3.0.co;2-6. Cancer. 2000. PMID: 10931451
346 results